000303012 001__ 303012
000303012 005__ 20250722114135.0
000303012 0247_ $$2doi$$a10.1080/21645515.2025.2532967
000303012 0247_ $$2pmid$$apmid:40679247
000303012 0247_ $$2ISSN$$a2164-5515
000303012 0247_ $$2ISSN$$a1554-8600
000303012 0247_ $$2ISSN$$a1554-8619
000303012 0247_ $$2ISSN$$a2164-554X
000303012 037__ $$aDKFZ-2025-01459
000303012 041__ $$aEnglish
000303012 082__ $$a610
000303012 1001_ $$00000-0002-9001-0207$$aMichaelides, Stefanos$$b0
000303012 245__ $$a11th Immunotherapy of Cancer conference (ITOC): A meeting report.
000303012 260__ $$aAustin, Tex.$$bLandes Bioscience$$c2025
000303012 3367_ $$2DRIVER$$aarticle
000303012 3367_ $$2DataCite$$aOutput Types/Journal article
000303012 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753107761_5170
000303012 3367_ $$2BibTeX$$aARTICLE
000303012 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303012 3367_ $$00$$2EndNote$$aJournal Article
000303012 520__ $$aThe Immunotherapy of Cancer (ITOC) meeting is an international conference providing a platform for immuno-oncologists worldwide to present and discuss their research and newest findings. Being held in Munich annually, the 11th edition took place in April 2025 and saw broad discussions about new concepts in the field of immuno-oncology, mixed with exciting clinical results but also with a glimpse back into the past. This was mirrored by the lifetime achievement award, given to Robert D. Schreiber for his groundbreaking work on the immune surveillance of cancer. ITOC11 impressively showcase how far immuno-oncology has come in a conference extending from the discipline's very beginnings up to some of the most exciting new findings in the field of cancer immunology. The conference has demonstrated that tumor immunology is not only about cancer and immune cells, but extends far beyond.
000303012 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000303012 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303012 650_7 $$2Other$$aCAR T cell therapy
000303012 650_7 $$2Other$$aITOC
000303012 650_7 $$2Other$$aImmunotherapy of Cancer
000303012 650_7 $$2Other$$aantibody therapy
000303012 650_7 $$2Other$$acellular therapy
000303012 650_7 $$2Other$$acombination therapy
000303012 650_7 $$2Other$$atumor immunology
000303012 650_7 $$2Other$$atumor vaccination
000303012 650_7 $$2NLM Chemicals$$aCancer Vaccines
000303012 650_2 $$2MeSH$$aHumans
000303012 650_2 $$2MeSH$$aNeoplasms: therapy
000303012 650_2 $$2MeSH$$aNeoplasms: immunology
000303012 650_2 $$2MeSH$$aImmunotherapy: methods
000303012 650_2 $$2MeSH$$aCongresses as Topic
000303012 650_2 $$2MeSH$$aCancer Vaccines: immunology
000303012 7001_ $$aHartmann, Viktoria$$b1
000303012 7001_ $$aNüssler, Volkmar$$b2
000303012 7001_ $$aZielinski, Christoph$$b3
000303012 7001_ $$0P:(DE-HGF)0$$avon Bergwelt-Baildon, Michael$$b4
000303012 7001_ $$0P:(DE-HGF)0$$aKobold, Sebastian$$b5
000303012 773__ $$0PERI:(DE-600)2664177-X$$a10.1080/21645515.2025.2532967$$gVol. 21, no. 1, p. 2532967$$n1$$p2532967$$tHuman vaccines & immunotherapeutics$$v21$$x2164-5515$$y2025
000303012 909CO $$ooai:inrepo02.dkfz.de:303012$$pVDB
000303012 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000303012 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000303012 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000303012 9141_ $$y2025
000303012 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHUM VACC IMMUNOTHER : 2022$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-08-08T20:20:27Z
000303012 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-08-08T20:20:27Z
000303012 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-08-08T20:20:27Z
000303012 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
000303012 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
000303012 9201_ $$0I:(DE-He78)MU01-20160331$$kMU01$$lDKTK Koordinierungsstelle München$$x0
000303012 980__ $$ajournal
000303012 980__ $$aVDB
000303012 980__ $$aI:(DE-He78)MU01-20160331
000303012 980__ $$aUNRESTRICTED